Welcome Guest

Table of Contents

Volume 8 |  Issue 6

Publication Date: May 2007
  • Abstract
  • No Access
  • Pay-Per View
  • Full Text
  • Add to Cart


Editorial

355
Moving Toward Personalized Therapy of Lung Cancer Through Pharmacogenomics
David R. Gandara, Philip Mack, Primo N. Lara, Jr
Meeting Highlights

359-363
Highlights from: the 24th Annual Meeting of the American Association for Cancer Research, Los Angeles, CA; April 2007
Aarati Ranganathan, Sabeeha Muneer, Primo N. Lara, Jr
Mini-Review

365-368
Prophylactic Cranial Irradiation for Patients with Lung Cancer
Thomas J. Pugh, Laurie E. Gaspar
Comprehensive Review

369-375
Gene Expression and Polymorphisms of DNA Repair Enzymes: Cancer Susceptibility and Response to Chemotherapy
Carlos Camps, Rafael Sirera, Vega Iranzo, Miquel Tarón, Rafael Rosell
Original Contributions

376-381
Prognostic Classification with Laboratory Parameters or Imaging Techniques in Small-Cell Lung Cancer
Wouter K. de Jong, Vaclav Fidler, Harry J. M. Groen

382-385
A Phase II Study of Single-Agent Oral Vinorelbine in Patients with Pretreated Advanced Non–Small-Cell Lung Cancer
David Rossi, Vincenzo Catalano, Paolo Alessandroni, Anna Fedeli, Stefano Luzi Fedeli, Paolo Giordani, Anna Maria Baldelli, Virginia Casadei, Monica Ceccolini, Marcello Ugolini, Donatella Dennetta, Giuseppina Catalano
Case Reports

386-388
Recurrent Bronchial Epithelial-Myoepithelial Carcinoma After Local Therapy
Alaa A. Muslimani, Madappa Kundranda, Sudhanshu Jain, Hamed A. Daw

389-391
Primary Pulmonary Rhabdomyosarcoma in Adults: Case Report and Review of Literature
Ajay Gupta, Mehar Chand Sharma, Vinod Kochupillai, Ganesan Kichendasse, Anuradha Gupta, Surender Atri, Kunjehari Medhi

392-395
Severe Paraneoplastic Hyponatremia and Hypoosmolality in a Patient with Small-Cell Lung Carcinoma: Syndrome of Inappropriate Antidiuretic Hormone Secretion Versus Atrial Natriuretic Peptide or Both?
Dan Radulescu, Delia Bunea, Sorin Pripon, Caius Duncea, Letitia Radulescu
Current Trial

396-398
A Randomized Phase II Study of Sorafenib/Gemcitabine or Sorafenib/Erlotinib for Advanced Non–Small-Cell Lung Cancer in Elderly Patients or Patients with a Performance Status of 2: Treatment Rationale and Protocol Dynamics
Cesare Gridelli, Antonio Rossi, Floriana Mongillo, Maria Bareschino, Paolo Maione, Fortunato Ciardiello
Clinical Trial

399
Selected Clinical Trials in lung Cancer
CIG Media Group
  1. https://www.ceteresopolitano.org/
  2. https://www.crossingstoronto.com/
  3. https://www.jediism.org/
  4. https://www.badenumc.org/
  5. https://www.johnsevierchapter.org/
  6. https://www.trinitychapelmn.org/
  7. https://www.photogearnews.com/
  8. https://www.alz-nova.org/
  9. https://www.cigjournals.com/
  10. https://summa-edu.com/
  11. https://cpawilmingtonnc.org/
  12. https://bimometals.com/
  13. https://sosenvironmental.com/
  14. https://thefriary.org/
  15. https://post5theatre.org/
  1. Pengeluaran SDY